UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Factors Predicting Late Recurrence for Estrogen Receptor―Positive Breast Cancer

JNCI : Journal of the National Cancer Institute, 2013-10, Vol.105 (19), p.1504-1511

2013

Volltextzugriff (PDF)

An International Ki67 Reproducibility Study

JNCI : Journal of the National Cancer Institute, 2013-12, Vol.105 (24), p.1897-1906

2013

Volltextzugriff (PDF)

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

Journal of clinical oncology, 2011-11, Vol.29 (32), p.4273-4278

2011

Volltextzugriff (PDF)

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Breast cancer research : BCR, 2017-02, Vol.19 (1), p.16-16, Article 16

2017

Volltextzugriff (PDF)

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

Nature communications, 2023-07, Vol.14 (1), p.4017-4017, Article 4017

2023

Volltextzugriff (PDF)

The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer

Clinical cancer research, 2018-10, Vol.24 (19), p.4763-4770

2018

Volltextzugriff (PDF)

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Breast cancer research : BCR, 2023-04, Vol.25 (1), p.39-39, Article 39

2023

Volltextzugriff (PDF)

Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

Breast cancer research : BCR, 2019-12, Vol.21 (1), p.135-135, Article 135

2019

Volltextzugriff (PDF)

Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

Breast cancer research : BCR, 2020-01, Vol.22 (1), p.14-14, Article 14

2020

Volltextzugriff (PDF)

Comparative validation of the SP6 antibody to Ki67 in breast cancer

Journal of clinical pathology, 2010-09, Vol.63 (9), p.800-804

2010

Volltextzugriff (PDF)

“Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring

Human pathology, 2015-11, Vol.46 (11), p.1694-1704

2015

Volltextzugriff (PDF)

A simple digital image analysis system for automated Ki67 assessment in primary breast cancer

Histopathology, 2021-08, Vol.79 (2), p.200-209

2021

Volltextzugriff (PDF)

Abstract PO5-26-09: Digital image analysis and a novel set of cell line samples as aids in the development of a quantitative external quality assessment programme for Ki-67

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-26-09-PO5-26-09

2024

Volltextzugriff (PDF)

Abstract PS18-10: Intratumoural heterogeneity in PgR expression: Molecular and prognostic significance

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS18-10-PS18-10

2021

Volltextzugriff (PDF)

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Modern pathology, 2022-10, Vol.35 (10), p.1362-1369

2022

Volltextzugriff (PDF)

Effects of cyclin D-1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Breast cancer research : BCR, 2012, Vol.14 (2)

2012

Volltextzugriff (PDF)

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Breast cancer research : BCR, 2012-04, Vol.14 (2), p.R57-R57, Article R57

2012

Volltextzugriff (PDF)

Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors

Clinical cancer research, 2019-12, Vol.25 (24), p.7485-7496

2019

Volltextzugriff (PDF)

Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study

Journal of clinical pathology, 2016-02, Vol.69 (2), p.128-135

2016

Volltextzugriff (PDF)

Abstract P5-10-06: Risk of recurrence estimates with IHC4 are tolerant of variations in staining and scoring

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P5-P5-10-06

2015

Volltextzugriff (PDF)

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

Breast cancer research : BCR, 2016-04, Vol.18 (1), p.39-39, Article 39

2016

Volltextzugriff (PDF)

The spatio-temporal evolution of lymph node spread in early breast cancer

Clinical cancer research, 2018-06, Vol.24 (19), p.4763-4770

2018

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Factors Predicting Late Recurrence for Estrogen Receptor―Positive Breast Cancer

An International Ki67 Reproducibility Study

Prognostic Value of a Combined Estrogen Receptor, Progesterone Receptor, Ki-67, and Human Epidermal Growth Factor Receptor 2 Immunohistochemical Score and Comparison With the Genomic Health Recurrence Score in Early Breast Cancer

Biomarker analysis of the NeoSphere study: pertuzumab, trastuzumab, and docetaxel versus trastuzumab plus docetaxel, pertuzumab plus trastuzumab, or pertuzumab plus docetaxel for the neoadjuvant treatment of HER2-positive breast cancer

Molecular profiling of aromatase inhibitor sensitive and resistant ER+HER2- postmenopausal breast cancers

The Spatiotemporal Evolution of Lymph Node Spread in Early Breast Cancer

Clinico-pathologic relationships with Ki67 and its change with short-term aromatase inhibitor treatment in primary ER + breast cancer: further results from the POETIC trial (CRUK/07/015)

Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

An international study to increase concordance in Ki67 scoring

Correction to: Combination of mTORC1/2 inhibitor vistusertib plus fulvestrant in vitro and in vivo targets oestrogen receptor-positive endocrine-resistant breast cancer

Comparative validation of the SP6 antibody to Ki67 in breast cancer

“Score the Core” Web-based pathologist training tool improves the accuracy of breast cancer IHC4 scoring

A simple digital image analysis system for automated Ki67 assessment in primary breast cancer

Abstract PO5-26-09: Digital image analysis and a novel set of cell line samples as aids in the development of a quantitative external quality assessment programme for Ki-67

Abstract PS18-10: Intratumoural heterogeneity in PgR expression: Molecular and prognostic significance

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration

Effects of cyclin D-1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study

Early Enrichment of ESR1 Mutations and the Impact on Gene Expression in Presurgical Primary Breast Cancer Treated with Aromatase Inhibitors

Risk of recurrence estimates with IHC4+C are tolerant of variations in staining and scoring: an analytical validity study

Abstract P5-10-06: Risk of recurrence estimates with IHC4 are tolerant of variations in staining and scoring

Heterogeneity in global gene expression profiles between biopsy specimens taken peri-surgically from primary ER-positive breast carcinomas

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

The spatio-temporal evolution of lymph node spread in early breast cancer

Suchergebnisse filtern